Gilead Sciences, Inc. today announced new research to be presented at The Liver Meeting® 2024, hosted by the American Association for the Study of Liver Diseases (AASLD) from November 15-19 in San ...

Global Thrombocytopenia Treatment IndustryThe global Thrombocytopenia Treatment Market is projected to experience significant ...

Patients with well-compensated NASH cirrhosis and three metabolic risk factors were selected for inclusion in the study.

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED ...

BioVie Inc. (Nasdaq: BIVI), (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological ...

Vivet Therapeutics Presents Three Posters on Cerebrotendinous Xanthomatosis Program and Novel AAV Gene Delivery Platform at European Society of Gene and Cell Therapy Annual Congress 2024 ...

Appalachian Diseases of Despair," a new report from the Appalachian Regional Commission (ARC) co-authored by East Tennessee ...

WEIGHT-LOSS jabs are the most talked about drugs of the moment. And with new studies popping up almost every week revealing ...

Going forward, SeaStar Medical will recognize 100% of revenue generated from QUELIMMUNE sales in the U.S., which corresponds ...

Ever heard of bitterleaf juice? It’s not common, right? See the health benefits of bitterleaf juice for your liver and digestive system: ...

WEIGHT-LOSS jabs are the most talked about drugs of the moment. And with new studies popping up almost every week revealing more benefits of these powerful medicines, it’s no wonder appetite ...

Drs Kathy Miller and Nancy U. Lin discuss central nervous system involvement in HER2 positive breast cancer, including the biology and management of patients.